US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Apollomics Inc (APLM)
Apollomics Inc (APLM) ニュース

APLM

Apollomics (APLM)

Apollomics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:APLM

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/09	05 : 05	GlobeNewswire Inc.	Apollomics Announces Private Placement Financing and Addition to Board of Directors	NASDAQ:APLM	Apollomics Inc
2024/04/25	21 : 30	GlobeNewswire Inc.	Apollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas with MET Fusion Gene	NASDAQ:APLM	Apollomics Inc
2024/04/10	20 : 00	GlobeNewswire Inc.	Apollomics Presents Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting	NASDAQ:APLM	Apollomics Inc
2024/04/02	21 : 00	GlobeNewswire Inc.	Apollomics Announces Poster Presentations of Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting	NASDAQ:APLM	Apollomics Inc
2024/03/28	20 : 00	GlobeNewswire Inc.	Apollomics Highlights Clinical Progress and Reports Full Year 2023 Financial Results	NASDAQ:APLM	Apollomics Inc
2024/03/26	21 : 00	GlobeNewswire Inc.	Apollomics to Announce Full Year 2023 Financial Results and Host Conference Call on March 28, 2024	NASDAQ:APLM	Apollomics Inc
2024/03/04	21 : 00	GlobeNewswire Inc.	Apollomics Appoints Matthew Plunkett, Ph.D. as Chief Financial Officer	NASDAQ:APLM	Apollomics Inc
2024/02/07	21 : 00	GlobeNewswire Inc.	Apollomics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	NASDAQ:APLM	Apollomics Inc
2024/01/20	06 : 15	GlobeNewswire Inc.	Apollomics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency	NASDAQ:APLM	Apollomics Inc
2024/01/18	06 : 30	GlobeNewswire Inc.	Apollomics to Participate in a Fireside Chat at the B. Riley Securities’ 2024 Virtual Oncology Conference	NASDAQ:APLM	Apollomics Inc
2024/01/03	21 : 00	GlobeNewswire Inc.	Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia	NASDAQ:APLM	Apollomics Inc
2024/01/03	06 : 30	GlobeNewswire Inc.	Apollomics to Present at the 2024 Biotech Showcase	NASDAQ:APLM	Apollomics Inc
2023/12/04	21 : 00	GlobeNewswire Inc.	Apollomics Presents Interim Data from Two Ongoing Phase 2 Clinical Trials with Vebreltinib in NSCLC Patients with MetExon14 Skipping Mutation	NASDAQ:APLM	Apollomics Inc
2023/11/29	21 : 30	GlobeNewswire Inc.	Apollomics to Participate in a Fireside Chat at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference	NASDAQ:APLM	Apollomics Inc
2023/11/28	21 : 00	GlobeNewswire Inc.	Apollomics Announces Presentation of Vebreltinib Data at the 2023 IASLC North America Conference on Lung Cancer (NACLC)	NASDAQ:APLM	Apollomics Inc
2023/11/16	22 : 30	GlobeNewswire Inc.	Apollomics Announces the First Approval of Vebreltinib for MET Exon 14 Skip Non-Small Cell Lung Cancer	NASDAQ:APLM	Apollomics Inc
2023/10/31	21 : 30	GlobeNewswire Inc.	Apollomics Announces Two New Cohorts in Global Phase 2 SPARTA Study of Vebreltinib in Non-Small Cell Lung Cancer and Other Solid Tumors with MET Dysregulation	NASDAQ:APLM	Apollomics Inc
2023/10/26	21 : 50	GlobeNewswire Inc.	Apollomics Announces Report of Activity of Vebreltinib in Glioblastoma Multiforme (GBM) with PTPRZ-MET Fusion	NASDAQ:APLM	Apollomics Inc
2023/10/23	21 : 30	GlobeNewswire Inc.	Apollomics Announces Efficacy of Vebreltinib in NSCLC Patients with MetEx14 Skipping Mutation Achieving an Overall Response Rate (ORR) of 75%	NASDAQ:APLM	Apollomics Inc
2023/10/17	07 : 55	GlobeNewswire Inc.	Apollomics Announces Presentations of Vebreltinib Data at ESMO 2023	NASDAQ:APLM	Apollomics Inc
2023/09/29	05 : 17	GlobeNewswire Inc.	Apollomics Reports First Half 2023 Financial Results and Provides Corporate Update	NASDAQ:APLM	Apollomics Inc
2023/09/06	20 : 00	GlobeNewswire Inc.	Apollomics to Present at the H.C. Wainwright 25th Annual Global Investment Conference	NASDAQ:APLM	Apollomics Inc
2023/04/11	21 : 30	GlobeNewswire Inc.	Apollomics Co-Founder and President, Sanjeev Redkar, Ph.D., to Speak at 23rd Annual R. Bryan Miller Symposium	NASDAQ:APLM	Apollomics Inc
2023/04/10	22 : 01	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:APLM	Apollomics Inc
2023/04/01	05 : 01	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:APLM	Apollomics Inc
2023/03/31	20 : 40	PR Newswire (US)	Qiming Venture Partners Welcomes Apollomics' Successful IPO on Nasdaq	NASDAQ:APLM	Apollomics Inc
2023/03/31	20 : 34	PR Newswire (US)	Qiming Venture Partners Welcomes Apollomics' Successful IPO on Nasdaq	NASDAQ:APLM	Apollomics Inc
2023/03/30	21 : 00	GlobeNewswire Inc.	Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq	NASDAQ:APLM	Apollomics Inc

Showing the most relevant articles for your search:NASDAQ:APLM

1

Jolt Health (PK)

Invesco Bulletshares 202...

Karoon Gas Australia (PK)

Amundi ETF ICAV

Imperial Petroleum

Maternus Kliniken

Tailwind Two Acquisition

Barclays 7.750%

Nuveen Esg High Yield Co...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約